Search

Search Results

1. Immunonkologie von Kopf-Hals-Tumoren

   Treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) is nowadays multidisciplinary. Therapeutic concepts include modern...

   Stefan Kasper, Timon Hussain, ... Stephan Lang in HNO

   Article 11 January 2019
   

2. Der prädiktive Wert der PD-L1-Diagnostik

   Immuno-oncology related treatments have become standard of care for many tumor entities. Numerous additional indications are currently under...

   H.-U. Schildhaus in Der Pathologe

   Article 26 October 2018
   

3. Inhaltsverzeichnis

   in Im Focus Onkologie

   Article 05 November 2018

4. Aktuelle Therapiestrategien beim Merkelzellkarzinom

   Anne-Charlotte Niesert, Markus Heppt, ... Carola Berking in InFo Onkologie

   Article 08 November 2018
   

5. Management immunvermittelter Nebenwirkungen

   Melanie Janning, Sonja Loges in hautnah dermatologie

   Article 22 January 2018
   

6. Immunonkologie von Kopf-Hals-Tumoren

   Treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) is nowadays multidisciplinary. Therapeutic concepts include modern...

   Stefan Kasper, Timon Hussain, ... Stephan Lang in best practice onkologie

   Article 19 October 2018
   

7. Frühe Diagnose kaum möglich — Prognose des PDAC immer noch sehr schlecht

   Stephan Hollerbach in Gastro-News

   Article 16 February 2019
   

8. Karzinomassoziierte Retinopathie (CAR) bei neuroendokrinem Uteruskarzinom

   A 75-year-old female patient presented with bilateral progressive loss of vision. Best corrected visual acuity (BCVA) was hand movements in the right...

   R. Siggel, T. Schick, ... S. Liakopoulos in Der Ophthalmologe

   Article 21 June 2018
   

9. Inhaltsverzeichnis

   in Im Focus Onkologie

   Article 10 July 2018

10. Management immunvermittelter Nebenwirkungen

    Melanie Janning, Sonja Loges in InFo Onkologie

    Article 18 September 2017
    

11. State of the Art in der Therapie von Hautkrebs, Lungen- und Nierenzellkarzinom

    in Forum

    Article 15 December 2017

12. Inhaltsverzeichnis

    in InFo Onkologie

    Article 03 October 2017

13. Metastasiertes Melanom: Duale Kinaseinhibition verbessert Prognose und Lebensqualität

    Andrea Grüthling in Im Focus Onkologie

    Article 19 December 2015

14. Nichtmelanozytärer Hautkrebs

    Non-melanoma skin cancer (NMSC) is the most common malignancy of the light-skinned population with an enormous socioeconomic impact. Historically...

    A. Zink in Der Hautarzt

    Article 10 October 2017

15. Molekulare Testungen bei onkologischen Erkrankungen

    Manfred Dietel in Im Focus Onkologie

    Article 17 July 2017
    

16. Molekularbiologische Grundlagen der immunonkologischen Therapie

    Sebastian Kobold in InFo Onkologie

    Article 18 September 2017
    

17. S3-Leitlinie Analkarzinom

    Anal cancer is a relatively rare tumor but has shown a continuous increase of new diseases with a doubling of the incidence in the last 20 years....

    Felix Aigner, Robert Siegel, ... Martin Dittmann in coloproctology

    Article 14 June 2021
    

18. Immuncheckpointinhibitoren

    Immune checkpoint inhibitors are currently the standard of care for various tumor entities. Pembrolizumab, ipilimumab and nivolumab as well as the...

    Sebastian Scheich, Martin Sebastian in Der Onkologe

    Article 24 April 2017

19. Epigenetische Strategien in der Krebstherapie

    Background

    Experimental insights into epigenetic regulatory mechanisms have dramatically altered our understanding of malignant diseases and...

    E. Hessmann, S.A. Johnsen, V. Ellenrieder in best practice onkologie

    Article 09 February 2017
    

20. EditorialNotes

    in Im Focus Onkologie

    Article 20 February 2017